Connected profiles2
Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Postmenopausal Osteoporosis peptide trials
3 selected ClinicalTrials.gov records carrying the official condition label Postmenopausal Osteoporosis. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
Registry records
3 selected records.
Connected peptides
2 profiles.
Registry update years
2007–2023 in selected records.
Indication intelligence
Selected evidence landscape
Trial phases2
Phase labels copied from the retained ClinicalTrials.gov versions.
Phase 4 (2)Phase 3 (1)
Registry statuses1
Overall statuses at each retained observation, not necessarily current today.
Completed (3)
Across the connected peptide profiles, PeptideScanner also carries 88 selected PubMed records and 7 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Postmenopausal Osteoporosis unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
Record added
ClinicalTrials.gov record NCT04026256
PeptideScanner retained ClinicalTrials.gov record NCT04026256 at 2026-07-30T19:09:38.366Z. Its registry update date was 2023-08-02, and PeptideScanner's reviewed identity mapping was teriparatide.
- PeptideScanner change date
- August 14, 2026
- Cited source date
- August 2, 2023
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT04064411
PeptideScanner retained ClinicalTrials.gov record NCT04064411 at 2026-07-30T19:16:22.171Z. Its registry update date was 2023-02-15, and PeptideScanner's reviewed identity mapping was abaloparatide.
- PeptideScanner change date
- August 14, 2026
- Cited source date
- February 15, 2023
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT00079924
PeptideScanner retained ClinicalTrials.gov record NCT00079924 at 2026-07-30T22:39:13.107Z. Its registry update date was 2007-05-25, and PeptideScanner's reviewed identity mapping was teriparatide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- May 25, 2007
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Teriparatide · 2023-08-02
ClinicalTrials.gov record NCT04026256
Completed at the retained observation.
Open attributed record →Abaloparatide · 2023-02-15
ClinicalTrials.gov record NCT04064411
Completed at the retained observation.
Open attributed record →Teriparatide · 2007-05-25
ClinicalTrials.gov record NCT00079924
Completed at the retained observation.
Open attributed record →